Primary Prevention With Statins in the Elderly

Первичная профилактика с применением статинов у пожилых людей
Martin Bødtker Mortensen, Erling Falk
2018-01-01

Atherosclerotic cardiovascular diseaseClinical guidelinesElderly populationPrimary preventionStatin therapy
The burden of atherosclerotic cardiovascular disease (ASCVD) in high-income countries is mostly borne by the elderly. With increasing life expectancy, clear guidance on sensible use of statin therapy to prevent a first and potentially devastating ASCVD event is critically important to ensure a healthy aging population. Since 2013, 5 major North American and European guidelines on statin use in primary prevention of ASCVD have been released by the American College of Cardiology/American Heart Association, the UK National Institute for Health and Care Excellence, the Canadian Cardiovascular Society, U.S. Preventive Services Task Force, and the European Society of Cardiology/European Atherosclerosis Society. Guidance on using statin therapy in primary ASCVD prevention in the growing elderly population (>65 years of age) differs markedly. The authors discuss the discrepant recommendations, place them into the context of available evidence, and identify circumstances in which uncertainty may hamper the appropriate use of statins in the elderly.
1
Atherosclerotic cardiovascular disease imposes most of its burden in high-income countries on elderly populations, making primary prevention increasingly important.
2
Five major North American and European guidelines issued since 2013 provide markedly different recommendations for statin therapy in adults older than 65 years.
3
The abstract highlights uncertainty in the evidence base as a major factor potentially hindering appropriate statin use for primary ASCVD prevention in elderly people.
4
The paper contextualizes discrepant guideline recommendations against available evidence and identifies clinical circumstances where statin decisions remain uncertain.

Statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults over 65 years of age

Guideline recommendations, supporting evidence, and uncertainty regarding appropriate statin use in elderly primary prevention

Publication Details
Publication Date
2018-01-01
Journal
Publisher
ISSN
Cited by
161
Access Type
Author Information
Authors
Martin Bødtker Mortensen
Erling Falk
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%